Heart dose and cardiac comorbidities influence death with a cardiac cause following hypofractionated radiotherapy for lung cancer

BACKGROUND: There is increasing evidence of cardiac toxicity of thoracic radiotherapy however, it is difficult to draw conclusions on cardiac dose constraints due to the heterogeneity of published studies. Moreover, few studies record data on cause of death. The aim of this paper is to investigate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Banfill, Kathryn, Abravan, Azadeh, van Herk, Marcel, Sun, Fei, Franks, Kevin, McWilliam, Alan, Faivre-Finn, Corinne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592751/
https://www.ncbi.nlm.nih.gov/pubmed/36303830
http://dx.doi.org/10.3389/fonc.2022.1007577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592751/
https://www.ncbi.nlm.nih.gov/pubmed/36303830
http://dx.doi.org/10.3389/fonc.2022.1007577

Ejemplares similares